Delve Bio develops metagenomic next-generation sequencing diagnostics for unbiased pathogen detection in infectious diseases like meningitis and encephalitis.
Get notified the moment Delve Bio files a new round, hires execs, or shows traction signals.
Create free accountAbout this data
FlareSight surfaces funding data from SEC Form D filings within hours of submission. Browse our full startup funding database to find more recently funded companies.